Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1029

1.

Does spiritual and religious orientation impact the clinical practice of healthcare providers?

Palmer Kelly E, Hyer M, Payne N, Pawlik TM.

J Interprof Care. 2020 Jan 13:1-8. doi: 10.1080/13561820.2019.1709426. [Epub ahead of print]

PMID:
31928484
2.

Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study Group.

Armstrong EA, Beal EW, Lopez-Aguiar AG, Poultsides G, Cannon JG, Rocha F, Crown A, Barrett J, Ronnkleiv-Kelly S, Fields RC, Krasnick BA, Idrees K, Smith PM, Nathan H, Beems MV, Maithel SK, Schmidt CR, Pawlik TM, Dillhoff M.

Am Surg. 2019 Dec 1;85(12):1334-1340.

PMID:
31908214
3.

Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortium.

Sahara K, Tsilimigras DI, Maithel SK, Abbott DE, Poultsides GA, Hatzaras I, Fields RC, Weiss M, Scoggins C, Isom CA, Idrees K, Shen P, Endo I, Pawlik TM; and the US Extrahepatic Biliary Malignancy Consortium.

J Surg Oncol. 2020 Jan 6. doi: 10.1002/jso.25825. [Epub ahead of print]

PMID:
31907941
4.

Hospital variation in Textbook Outcomes following curative-intent resection of hepatocellular carcinoma: an international multi-institutional analysis.

Tsilimigras DI, Mehta R, Merath K, Bagante F, Paredes AZ, Farooq A, Ratti F, Marques HP, Silva S, Soubrane O, Lam V, Poultsides GA, Popescu I, Grigorie R, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

HPB (Oxford). 2019 Dec 27. pii: S1365-182X(19)33221-6. doi: 10.1016/j.hpb.2019.12.005. [Epub ahead of print]

PMID:
31889626
5.

Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis.

Xing H, Sun LY, Yan WT, Quan B, Liang L, Li C, Zhou YH, Wang H, Zhong JH, Gu WM, Chen TH, Wang MD, Wu H, Pawlik TM, Lau WY, Wu MC, Shen F, Yang T.

Surgery. 2019 Dec 23. pii: S0039-6060(19)30741-X. doi: 10.1016/j.surg.2019.11.005. [Epub ahead of print]

PMID:
31879090
6.

Optimal Location for Centralization of Hospitals Performing Pancreas Resection in California.

Diaz A, Pawlik TM.

JAMA Surg. 2019 Dec 26. doi: 10.1001/jamasurg.2019.4937. [Epub ahead of print] No abstract available.

PMID:
31877206
7.

Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.

Sahara K, Tsilimigras DI, Mehta R, Moro A, Paredes AZ, Lopez-Aguiar AG, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Poultsides GA, Makris E, Cho C, Beems M, Dillhoff M, Maithel SK, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Dec 14. doi: 10.1245/s10434-019-08120-1. [Epub ahead of print]

PMID:
31838609
8.

ASO Author Reflections: Trends in the Number of Lymph Nodes Evaluated Following Resection of Pancreatic Neuroendocrine Tumors-An Increasing Adoption of the AJCC Guidelines?

Sahara K, Tsilimigras DI, Pawlik TM.

Ann Surg Oncol. 2019 Dec 12. doi: 10.1245/s10434-019-08134-9. [Epub ahead of print] No abstract available.

PMID:
31832917
9.

Redefining Conditional Overall and Disease-Free Survival After Curative Resection for Intrahepatic Cholangiocarcinoma: a Multi-institutional, International Study of 1221 patients.

Hu LS, Zhang XF, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Itaru E, Lv Y, Pawlik TM.

J Gastrointest Surg. 2019 Dec 10. doi: 10.1007/s11605-019-04472-x. [Epub ahead of print]

PMID:
31823320
10.

Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection.

Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM.

HPB (Oxford). 2019 Dec 7. pii: S1365-182X(19)33207-1. doi: 10.1016/j.hpb.2019.11.009. [Epub ahead of print]

PMID:
31822386
11.

Development and validation of a real-time mortality risk calculator before, during and after hepatectomy: an analysis of the ACS NSQIP database.

Sahara K, Tsilimigras DI, Paredes AZ, Farooq SA, Hyer JM, Moro A, Mehta R, Wu L, Endo I, Ejaz A, Cloyd J, Pawlik TM.

HPB (Oxford). 2019 Dec 4. pii: S1365-182X(19)33190-9. doi: 10.1016/j.hpb.2019.10.2446. [Epub ahead of print]

PMID:
31812552
12.

The impact of liver resection on survival for locally advanced intrahepatic cholangiocarcinoma tumors: A propensity score analysis.

Moustafa M, Fasolo E, Bassi D, D'amico FE, Gringeri E, Pawlik TM, Cillo U.

Eur J Surg Oncol. 2019 Nov 17. pii: S0748-7983(19)31446-5. doi: 10.1016/j.ejso.2019.11.502. [Epub ahead of print]

PMID:
31812289
13.

How Safe Are Safety-Net Hospitals? Opportunities to Improve Outcomes for Vulnerable Patients Undergoing Hepatopancreaticobiliary Surgery.

Farooq A, Paredes AZ, Merath K, Hyer JM, Mehta R, Sahara K, Tsilimigras DI, Moro A, Wu L, Cloyd J, Ejaz A, Pawlik TM.

J Gastrointest Surg. 2019 Dec 2. doi: 10.1007/s11605-019-04428-1. [Epub ahead of print]

PMID:
31792898
14.

CMS Hospital Compare System of Star Ratings and Surgical Outcomes Among Patients Undergoing Surgery for Cancer: Do the Ratings Matter?

Mehta R, Paredes AZ, Tsilimigras DI, Farooq A, Sahara K, Merath K, Hyer JM, White S, Ejaz A, Tsung A, Dillhoff M, Cloyd JM, Pawlik TM.

Ann Surg Oncol. 2019 Dec 2. doi: 10.1245/s10434-019-08088-y. [Epub ahead of print]

PMID:
31792714
15.

Redefining the "Honor Roll:" do hospital rankings predict surgical outcomes or receipt of quality surgical care?

Mehta R, Paredes AZ, Pawlik TM.

Am J Surg. 2019 Nov 26. pii: S0002-9610(19)31543-0. doi: 10.1016/j.amjsurg.2019.11.029. [Epub ahead of print]

PMID:
31791549
16.
17.

Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial.

Xia Y, Li J, Liu G, Wang K, Qian G, Lu Z, Yang T, Yan Z, Lei Z, Si A, Wan X, Zhang H, Gao C, Cheng Z, Pawlik TM, Wang H, Lau WY, Wu M, Shen F.

JAMA Oncol. 2019 Nov 27. doi: 10.1001/jamaoncol.2019.4477. [Epub ahead of print]

PMID:
31774468
18.

New and emerging systemic therapy options for well-differentiated gastroenteropancreatic neuroendocrine tumors.

Scoville SD, Cloyd JM, Pawlik TM.

Expert Opin Pharmacother. 2020 Feb;21(2):183-191. doi: 10.1080/14656566.2019.1694003. Epub 2019 Nov 24.

PMID:
31760823
19.

Precision Medicine in Surgical Oncology.

Pawlik TM.

Surg Oncol Clin N Am. 2020 Jan;29(1):xiii-xiv. doi: 10.1016/j.soc.2019.09.002. No abstract available.

PMID:
31757317
20.

Impact of Preoperative Cholangitis on Short-term Outcomes Among Patients Undergoing Liver Resection.

Sahara K, Merath K, Hyer JM, Paredes AZ, Tsilimigras DI, Mehta R, Farooq SA, Moro A, Wu L, White S, Endo I, Pawlik TM.

J Gastrointest Surg. 2019 Nov 19. doi: 10.1007/s11605-019-04430-7. [Epub ahead of print]

PMID:
31745898
21.

Interaction of Surgeon Volume and Nurse-to-Patient Ratio on Post-operative Outcomes of Medicare Beneficiaries Following Pancreaticoduodenectomy.

Paredes AZ, Hyer JM, Tsilimigras DI, Sahara K, White S, Pawlik TM.

J Gastrointest Surg. 2019 Nov 19. doi: 10.1007/s11605-019-04449-w. [Epub ahead of print]

PMID:
31745895
22.

Photodynamic therapy may provide a benefit over systemic chemotherapy among non-surgically managed patients with extrahepatic cholangiocarcinoma.

Wu L, Merath K, Farooq A, Hyer JM, Tsilimigras DI, Paredes AZ, Mehta R, Sahara K, Shen F, Pawlik TM.

J Surg Oncol. 2019 Nov 19. doi: 10.1002/jso.25773. [Epub ahead of print]

PMID:
31742706
23.

A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients.

Tsilimigras DI, Mehta R, Moris D, Sahara K, Bagante F, Paredes AZ, Moro A, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Soubrane O, Koerkamp BG, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Nov 14. doi: 10.1245/s10434-019-08067-3. [Epub ahead of print]

PMID:
31728792
24.

ASO Author Reflections: Use of Machine Learning to Identify Patients with Intrahepatic Cholangiocarcinoma Who Could Benefit More from Neoadjuvant Therapies.

Tsilimigras DI, Mehta R, Pawlik TM.

Ann Surg Oncol. 2019 Nov 11. doi: 10.1245/s10434-019-08068-2. [Epub ahead of print] No abstract available.

PMID:
31712926
25.

Accessing surgical care for pancreaticoduodenectomy: Patient variation in travel distance and choice to bypass hospitals to reach higher volume centers.

Diaz A, Burns S, Paredes AZ, Pawlik TM.

J Surg Oncol. 2019 Dec;120(8):1318-1326. doi: 10.1002/jso.25750. Epub 2019 Nov 7.

PMID:
31701535
26.

Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.

Tsilimigras DI, Mehta R, Moris D, Sahara K, Bagante F, Paredes AZ, Farooq A, Ratti F, Marques HP, Silva S, Soubrane O, Lam V, Poultsides GA, Popescu I, Grigorie R, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Nov 6. doi: 10.1245/s10434-019-08025-z. [Epub ahead of print]

PMID:
31696396
27.

ASO Author Reflections: Resection for Hepatocellular Carcinoma Beyond the BCLC Guidelines-How Can Machine Learning Techniques Help?

Tsilimigras DI, Pawlik TM.

Ann Surg Oncol. 2019 Nov 4. doi: 10.1245/s10434-019-08036-w. [Epub ahead of print] No abstract available.

PMID:
31686343
28.

U.S. News and World Report hospital ranking and surgical outcomes among patients undergoing surgery for cancer.

Mehta R, Merath K, Farooq A, Sahara K, Tsilimigras DI, Ejaz A, Hyer JM, Paredes AZ, Dillhoff M, Cloyd JM, Pawlik TM.

J Surg Oncol. 2019 Dec;120(8):1327-1334. doi: 10.1002/jso.25751. Epub 2019 Nov 3.

PMID:
31680251
29.

Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined.

Zhang XF, Wu XN, Tsilimigras DI, Poultsides G, Rocha F, Abbott DE, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM; other members of the US Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Dec;120(8):1302-1310. doi: 10.1002/jso.25753. Epub 2019 Nov 3.

PMID:
31680243
30.

A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B.

Yang T, Xing H, Wang G, Wang N, Liu M, Yan C, Li H, Wei L, Li S, Fan Z, Shi M, Chen W, Cai S, Pawlik TM, Soh A, Beshiri A, Lau WY, Wu M, Zheng Y, Shen F.

Clin Chem. 2019 Dec;65(12):1543-1553. doi: 10.1373/clinchem.2019.308965. Epub 2019 Oct 31.

PMID:
31672853
31.

Can We Improve Prediction of Adverse Surgical Outcomes? Development of a Surgical Complexity Score Using a Novel Machine Learning Technique.

Hyer JM, White S, Cloyd J, Dillhoff M, Tsung A, Pawlik TM, Ejaz A.

J Am Coll Surg. 2020 Jan;230(1):43-52.e1. doi: 10.1016/j.jamcollsurg.2019.09.015. Epub 2019 Oct 28.

PMID:
31672674
32.

Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?

Wiseman JT, Kimbrough C, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Lee B, Fackche N, Greer J, Pawlik TM, Abdel-Misih S, Cloyd JM.

Ann Surg Oncol. 2019 Oct 28. doi: 10.1245/s10434-019-07964-x. [Epub ahead of print]

PMID:
31659645
33.

Coaxial projective imaging system for surgical navigation and telementoring.

Zhang F, Zhu X, Gao J, Wu B, Liu P, Shao P, Xu M, Pawlik TM, Martin EW, Xu RX.

J Biomed Opt. 2019 Oct;24(10):1-9. doi: 10.1117/1.JBO.24.10.105002.

34.

Routine Intensive Care Unit Admission Following Liver Resection: What Is the Value Proposition?

Merath K, Cerullo M, Farooq A, Canner JK, He J, Tsilimigras DI, Mehta R, Paredes AZ, Sahara K, Dillhoff M, Tsung A, Cloyd J, Ejaz A, Pawlik TM.

J Gastrointest Surg. 2019 Oct 19. doi: 10.1007/s11605-019-04408-5. [Epub ahead of print]

PMID:
31630368
35.

Understanding the use of attachment theory applied to the patient-provider relationship in cancer care: Recommendations for future research and clinical practice.

Palmer Kelly E, Tsilimigras DI, Hyer JM, Pawlik TM.

Surg Oncol. 2019 Dec;31:101-110. doi: 10.1016/j.suronc.2019.10.007. Epub 2019 Oct 5. Review.

PMID:
31622916
36.

Hepatopancreatobiliary Surgery: the Role of Clinical Resources and Variation in Performance of Hospitals Located in "Distressed" Communities.

Farooq A, Paredes AZ, Merath K, Mehta R, Moro A, Wu L, Sahara K, Hyer JM, Tsilimigras DI, Diaz A, Pawlik TM.

J Gastrointest Surg. 2019 Oct 16. doi: 10.1007/s11605-019-04401-y. [Epub ahead of print]

PMID:
31621025
37.

Evaluation of costs and outcomes of physician-owned hospitals across common surgical procedures.

Bae J, Hyer JM, Paredes AZ, Farooq A, Rice DR, White S, Tsilimigras DI, Ejaz A, Pawlik TM.

Am J Surg. 2019 Oct 8. pii: S0002-9610(19)31187-0. doi: 10.1016/j.amjsurg.2019.10.008. [Epub ahead of print]

PMID:
31619377
38.

Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome.

Klompenhouwer AJ, Dwarkasing RS, Doukas M, Pellegrino S, Vilgrain V, Paradis V, Soubrane O, Beane JD, Geller DA, Nalesnik MA, Tripke V, Lang H, Schmelzle M, Pratschke J, Schöning W, Beal E, Sun S, Pawlik TM, de Man RA, Ijzermans JNM.

HPB (Oxford). 2019 Oct 13. pii: S1365-182X(19)30716-6. doi: 10.1016/j.hpb.2019.09.004. [Epub ahead of print]

PMID:
31619346
39.

Potential survival benefit of radiofrequency ablation for small solitary intrahepatic cholangiocarcinoma in nonsurgically managed patients: A population-based analysis.

Wu L, Tsilimigras DI, Farooq A, Hyer JM, Merath K, Paredes AZ, Mehta R, Sahara K, Shen F, Pawlik TM.

J Surg Oncol. 2019 Dec;120(8):1358-1364. doi: 10.1002/jso.25736. Epub 2019 Oct 15.

PMID:
31614000
40.

Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study.

Xing H, Zhang WG, Cescon M, Liang L, Li C, Wang MD, Wu H, Lau WY, Zhou YH, Gu WM, Wang H, Chen TH, Zeng YY, Schwartz M, Pawlik TM, Serenari M, Shen F, Wu MC, Yang T.

HPB (Oxford). 2019 Oct 10. pii: S1365-182X(19)30718-X. doi: 10.1016/j.hpb.2019.09.006. [Epub ahead of print]

PMID:
31607637
41.

Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.

Tsilimigras DI, Bagante F, Moris D, Merath K, Paredes AZ, Sahara K, Ratti F, Marques HP, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

Surgery. 2019 Dec;166(6):967-974. doi: 10.1016/j.surg.2019.08.010. Epub 2019 Oct 9.

PMID:
31606196
42.

Correction to: Current Approaches in the Management of Hepatic Adenomas.

Tsilimigras DI, Rahnemai-Azar AA, Ntanasis-Stathopoulos I, Gavriatopoulou M, Moris D, Spartalis E, Cloyd JM, Weber SM, Pawlik TM.

J Gastrointest Surg. 2019 Oct 10. doi: 10.1007/s11605-019-04372-0. [Epub ahead of print]

PMID:
31602557
43.

Hepatocellular carcinoma: an update on investigational drugs in phase I and II clinical trials.

Noonan A, Pawlik TM.

Expert Opin Investig Drugs. 2019 Nov;28(11):941-949. doi: 10.1080/13543784.2019.1677606. Epub 2019 Oct 12. Review.

PMID:
31590579
44.

Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: A multi-institutional study of 392 cases.

Dong DH, Zhang XF, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM; other members of the US Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Dec;120(7):1071-1079. doi: 10.1002/jso.25716. Epub 2019 Sep 30.

PMID:
31571225
45.

Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Beal EW, Ahmed A, Grotz T, Leiting J, Fournier KF, Lee AJ, Dineen S, Dessureault S, Baumgartner JM, Veerapong J, Clarke C, Strong E, Maithel SK, Zaidi MY, Patel S, Dhar V, Hendrix R, Lambert L, Johnston F, Fackche N, Raoof M, LaRocca C, Ronnekleiv-Kelly S, Pokrzywa C, Pawlik TM, Abdel-Misih S, Cloyd JM.

Am J Surg. 2019 Sep 19. pii: S0002-9610(19)30848-7. doi: 10.1016/j.amjsurg.2019.09.017. [Epub ahead of print]

PMID:
31558307
46.

Advances in the Diagnosis and Treatment of Patients with Intrahepatic Cholangiocarcinoma.

Ejaz A, Cloyd JM, Pawlik TM.

Ann Surg Oncol. 2020 Feb;27(2):552-560. doi: 10.1245/s10434-019-07873-z. Epub 2019 Sep 25.

PMID:
31555936
47.

Complex hepato-pancreato-biliary caseload during general surgery residency training: are we adequately training the next generation?

Diaz A, Schoenbrunner A, Dillhoff M, Cloyd JM, Ejaz A, Tsung A, Shirley LA, Harzman AE, Cochran A, Pawlik TM.

HPB (Oxford). 2019 Sep 21. pii: S1365-182X(19)30709-9. doi: 10.1016/j.hpb.2019.08.017. [Epub ahead of print]

PMID:
31551139
48.

Conditional disease-free survival after curative-intent liver resection for neuroendocrine liver metastasis.

Sahara K, Merath K, Tsilimigras DI, Hyer JM, Guglielmi A, Aldrighetti L, Weiss M, Fields RC, Poultsides GA, Maithel SK, Endo I, Pawlik TM, Other Members Of The U S Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Dec;120(7):1087-1095. doi: 10.1002/jso.25713. Epub 2019 Sep 24.

PMID:
31550406
49.

Real-world role of performance status in surgical resection for hepatocellular carcinoma: A multicenter study.

Wu H, Xing H, Liang L, Huang B, Li C, Lau WY, Zhou YH, Gu WM, Wang H, Chen TH, Zhang YM, Zeng YY, Pawlik TM, Wang MD, Wu MC, Shen F, Yang T.

Eur J Surg Oncol. 2019 Dec;45(12):2360-2368. doi: 10.1016/j.ejso.2019.09.009. Epub 2019 Sep 12.

PMID:
31543386
50.

Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review.

Montalvo-Jave EE, Rahnemai-Azar AA, Papaconstantinou D, Deloiza ME, Tsilimigras DI, Moris D, Mendoza-Barrera GE, Weber SM, Pawlik TM.

Surg Oncol. 2019 Dec;31:83-89. doi: 10.1016/j.suronc.2019.09.006. Epub 2019 Sep 13. Review.

PMID:
31541911

Supplemental Content

Loading ...
Support Center